Streamline Health Solutions (NASDAQ:STRM) Price Target Cut to $2.00 by Analysts at Lake Street Capital

Streamline Health Solutions (NASDAQ:STRM) had its price objective reduced by Lake Street Capital from $3.00 to $2.00 in a research report released on Monday, FlyOnTheWall reports.

Separately, StockNews.com assumed coverage on shares of Streamline Health Solutions in a research note on Wednesday, September 13th. They issued a sell rating on the stock.

Streamline Health Solutions Stock Down 4.3 %

Streamline Health Solutions stock opened at $0.75 on Monday. The company’s 50 day simple moving average is $1.20 and its 200 day simple moving average is $1.48. Streamline Health Solutions has a fifty-two week low of $0.68 and a fifty-two week high of $2.35. The firm has a market capitalization of $43.97 million, a price-to-earnings ratio of -3.73 and a beta of 1.27. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.80 and a quick ratio of 0.80.

Streamline Health Solutions (NASDAQ:STRM) last announced its quarterly earnings results on Thursday, September 14th. The company reported ($0.04) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.02. Streamline Health Solutions had a negative net margin of 44.61% and a negative return on equity of 31.35%. The firm had revenue of $5.77 million for the quarter.

Institutional Trading of Streamline Health Solutions

Institutional investors have recently made changes to their positions in the business. Harbert Fund Advisors Inc. increased its holdings in shares of Streamline Health Solutions by 18.6% in the fourth quarter. Harbert Fund Advisors Inc. now owns 4,824,212 shares of the company’s stock valued at $7,622,000 after purchasing an additional 757,575 shares during the last quarter. Cetera Investment Advisers bought a new stake in Streamline Health Solutions during the fourth quarter worth about $63,000. Dimensional Fund Advisors LP bought a new stake in Streamline Health Solutions during the first quarter worth about $56,000. Morgan Stanley lifted its position in Streamline Health Solutions by 3,400,000.0% during the fourth quarter. Morgan Stanley now owns 34,001 shares of the company’s stock worth $54,000 after purchasing an additional 34,000 shares during the period. Finally, HRT Financial LP bought a new stake in Streamline Health Solutions during the fourth quarter worth about $34,000. Institutional investors own 34.60% of the company’s stock.

Streamline Health Solutions Company Profile

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.